Alibaba Cloud - Free CT Image Analytics for COVID-19 - Whole Genome Sequencing Analysis for COVID-19 etc.
Alibaba Cloud - Free CT Image Analytics for COVID-19
This technology can assist realizing quantitative analysis, speeding up CT image analytics, avoiding errors caused by fatigue and adjusting treatment plans in time.
Free for public research institution
Email Your Submission: Free Computational and AI Platforms to Help Research, Analyze and Combat COVID-19 ("Program") is intended to support public research institutions worldwide for the research analysis and prevention of COVID-19. This technology is subject to availability upon confirmation. You can submit the summary and description of your research project to wanqing.hwq [at] alibaba-inc.com. All submissions will be reviewed for technical feasibility, and eligible applicants will be contacted for more details and the next steps of the process. Once the submission is successful, the applicant will get a certain amount of coupon according to the project, which is valid for 3months. The coupon can be used for all Alibaba cloud products, including HPC, ECS, and GPU, excluding marketplace products and 3rd party products.
Disclaimer: The technology is not intended to, by itself and without the exercise of professional judgment and clinical evaluation, diagnose any medical condition or disease or conclusively indicate the absence of any disease, including COVID-19 and the technology is not a substitute for diagnosis and treatment by a certified medical professional. The technology has not been thoroughly tested, and are not guaranteed in any way to be accurate, useful, sufficient, satisfactory, available, or otherwise fit for any purpose. To the maximum extent permissible under applicable law, the Solution is provided "AS IS," "WITH ALL FAULTS," and without any warranties or service guarantees.
Note: The accuracy is calculated using the model trained on about 5000 samples, and is tested based on a sample size of 660 tests with a 1:1:1 ratio of cases of COVID-19 pneumonia, common pneumonia, and other conditions.
Whole Genome Sequencing Analysis for COVID-19
When facing a severe epidemic such as COVID-19, rapid and accurate virus screening and detection is particularly important for maintaining control. The AI algorithm avoids the high missed detection rate of nearly 40% of PCR, and can accurately detect virus mutations and shorten the duration of genetic analysis of suspected cases from hours to just 30 minutes, greatly reducing the time of virus screening and detection.
To read disclaimer, click to see Disclaimer in FAQ.
- Rapid and accurate testing to improve the handling of local outbreaks
- Core algorithm optimization and comprehensive monitoring of COVID-19 development and changes
- Quick deployment and easy to use with modular and simplified operation and configuration
Elastic High Performance Computing Technology
The development of new drugs and vaccines for COVID-19 requires large amounts of data analysis, as well as large-scale literature screening and scientific computing. HPC and AI technology helps scientific research institutions to perform viral gene sequencing, conduct new drug research and development, and shorten the research and development cycle. The Global Health Drug Discovery Institute (GHDDI) has established a scientific data sharing platform and an AI drug screening platform for COVID-19 with the support of this center's open AI computing power. Some research institutions and universities have increased the speed of biological information transmission by 5 times, and reduced the virtual screening time for antiviral drugs from one month to one week.